Genotech Corporation (XKON:066830)

Genotech Statistics

Total Valuation

Genotech has a market cap or net worth of KRW 6.13 billion.

Market Cap	6.13B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Genotech has 5.60 million shares outstanding.

Current Share Class	5.60M
Shares Outstanding	5.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	48.66%
Owned by Institutions (%)	n/a
Float	2.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.84
PB Ratio	1.28
P/TBV Ratio	1.29
P/FCF Ratio	48.86
P/OCF Ratio	16.23
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 1.85.

Current Ratio	0.99
Quick Ratio	0.49
Debt / Equity	1.85
Debt / EBITDA	n/a
Debt / FCF	70.91
Interest Coverage	-2.64

Financial Efficiency

Return on equity (ROE) is -25.60% and return on invested capital (ROIC) is -4.56%.

Return on Equity (ROE)	-25.60%
Return on Assets (ROA)	-4.12%
Return on Invested Capital (ROIC)	-4.56%
Return on Capital Employed (ROCE)	-9.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.47
Inventory Turnover	2.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.39% in the last 52 weeks. The beta is 0.31, so Genotech's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-21.39%
50-Day Moving Average	1,132.06
200-Day Moving Average	1,332.27
Relative Strength Index (RSI)	47.07
Average Volume (20 Days)	55

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genotech had revenue of KRW 7.28 billion and -1.32 billion in losses. Loss per share was -280.00.

Revenue	7.28B
Gross Profit	962.09M
Operating Income	-1.01B
Pretax Income	-1.32B
Net Income	-1.32B
EBITDA	-347.19M
EBIT	-1.01B
Loss Per Share	-280.00

Balance Sheet

The company has 1.21 billion in cash and 8.89 billion in debt, giving a net cash position of -7.68 billion or -1,371.07 per share.

Cash & Cash Equivalents	1.21B
Total Debt	8.89B
Net Cash	-7.68B
Net Cash Per Share	-1,371.07
Equity (Book Value)	4.80B
Book Value Per Share	1,017.52
Working Capital	-55.69M

Cash Flow

In the last 12 months, operating cash flow was 377.41 million and capital expenditures -252.05 million, giving a free cash flow of 125.36 million.

Operating Cash Flow	377.41M
Capital Expenditures	-252.05M
Free Cash Flow	125.36M
FCF Per Share	22.39

Margins

Gross margin is 13.21%, with operating and profit margins of -13.90% and -18.14%.

Gross Margin	13.21%
Operating Margin	-13.90%
Pretax Margin	-18.14%
Profit Margin	-18.14%
EBITDA Margin	-4.77%
EBIT Margin	-13.90%
FCF Margin	1.72%

Dividends & Yields

Genotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.92%
Shareholder Yield	-9.92%
Earnings Yield	-21.57%
FCF Yield	2.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genotech has an Altman Z-Score of -0.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.11
Piotroski F-Score	3